Astrazeneca Pharma India Ltd. (ASTRAZEN): Astrazeneca Pharma India Share Price hits fresh 52-week low at Rs 7,114.50
- August 27, 2026
- Posted by: Harsh Piplani
- Category: News
Astrazeneca Pharma India Share Price fell to Rs 7,114.50, down 0.57% from the previous close of Rs 7,155.45, after touching a fresh 52-week low of Rs 7,085.05 on 27 August 2026 at 9:31 AM IST. The company’s market capitalisation stands at Rs 17,888.63 crore. This fresh yearly low makes Astrazeneca Pharma India Stock News relevant for investors tracking Astrazeneca Pharma India Share Price Today, especially because the supplied data confirms the price event but does not establish a company-specific catalyst. The move comes with a low day range and a modest turnover of Rs 0.08 crore, while the underlying fundamentals remain the central context for any Astrazeneca Pharma India Share Price review on Univest.
The stock opened at Rs 7,155.45, matched the day’s high at Rs 7,155.45 and then slipped to Rs 7,085.05, which is also the day low and the 52-week low. That leaves Astrazeneca Pharma India Share Price trading only a small distance above its yearly trough, a setup that is drawing attention in stock analysis and market update screens. Univest tracks this kind of event because it combines price action, valuation and sector context in one Astrazeneca Pharma India Share Price story.
Astrazeneca Pharma India Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 7,114.5 |
| Previous Close | Rs 7,155.45 |
| Today's Move | Rs -40.95 (-0.57%) |
| Open | Rs 7,155.45 |
| High | Rs 7,155.45 |
| Low | Rs 7,085.05 |
| Turnover | Rs 0.08 crore |
| Market Capitalisation | Rs 17,888.63 crore |
Astrazeneca Pharma India Ltd. (ASTRAZEN) traded at Rs 7,114.5. versus the previous close of Rs 7,155.45, a fall of 0.57%. The stock opened at Rs 7,155.45, reached Rs 7,155.45, touched Rs 7,085.05.
Astrazeneca Pharma India Share Price Today shows a clear fresh 52-week low event. The current price of Rs 7,114.50 is below the previous close of Rs 7,155.45 by Rs 40.95, or 0.57%. The stock opened at Rs 7,155.45, printed a high of Rs 7,155.45 and a low of Rs 7,085.05, with the low matching the 52-week low. Turnover stood at Rs 0.08 crore and market capitalisation at Rs 17,888.63 crore.
From a pure price-event perspective, the session confirmed a one-year low, not an all-time low. The current price is 0.42% above the day’s low and 0.57% below the previous close. For readers searching Astrazeneca Pharma India Share Price Live or Astrazeneca Pharma India Share Price Update, the key fact is that the stock is now marked by a fresh 52-week trough. Univest uses this daily price-led lens to keep Astrazeneca Pharma India Stock News focused on verified market data.
Astrazeneca Pharma India Ltd. (ASTRAZEN) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 17,888.63 crore |
| P/E Ratio | 105.46x |
| P/B Ratio | 19.78x |
| ROE | 23.02% |
| ROCE | 31.24% |
| EPS | Rs 67.85 |
| Book Value Per Share | Rs 361.68 |
| Dividend Yield | 0.5% |
Astrazeneca Pharma India Ltd. (ASTRAZEN) fundamental metrics show P/E 105.46x, P/B 19.78x, ROE 23.02%, ROCE 31.24%. These figures provide context only and are not a buy or sell signal.
Astrazeneca Pharma India Ltd. has a market capitalisation of Rs 17888.63 crore, which gives readers a sense of company size before judging valuation. On valuation, P/E at 105.46x, P/B at 19.78x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 23.02% and ROCE of 31.24%, helping investors compare shareholder returns and capital efficiency. Additional supplied metrics include EPS of Rs 67.85, book value per share of Rs 361.68, dividend yield of 0.5%, adding context to earnings, balance-sheet value and historical payout. Against the supplied same industry benchmark, these figures can be compared with benchmark median P/E of 30.54x, median ROE of 11.83%, median ROCE of 13.75%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 105.46x |
| Benchmark Median P/E | 30.54x |
| Benchmark Average P/E | 46.82x |
| Benchmark P/E Range | 3.19x to 671.51x |
| Company P/B Ratio | 19.78x |
| Benchmark Median P/B | 2.76x |
| Company ROE | 23.02% |
| Benchmark Median ROE | 11.83% |
| Company ROCE | 31.24% |
| Benchmark Median ROCE | 13.75% |
| Company Market Capitalisation | Rs 17,888.63 crore |
| Benchmark Median Market Cap | Rs 623.8 crore |
Astrazeneca Pharma India Ltd. (ASTRAZEN) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.
Astrazeneca Pharma India Ltd. (ASTRAZEN) has a P/E ratio of 105.46x, which is above the benchmark median of 30.54x, a difference of +245.32%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.
Astrazeneca Pharma India Ltd. (ASTRAZEN) has a ROE of 23.02%, which is above the benchmark median of 11.83%, a difference of +94.59%. Astrazeneca Pharma India Ltd. (ASTRAZEN) has a ROCE of 31.24%, which is above the benchmark median of 13.75%, a difference of +127.2%.
Track stocks falling to yearly lows through the Univest 52-week-low screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Eris Lifesciences Ltd. | ERIS | 18,146.79 | 28.17 | 4.48 | 13.81 | 13.59 |
| Suven Pharmaceuticals Ltd. | COHANCE | 17,040.89 | 166.41 | 4.57 | 14.2 | 18.44 |
| Caplin Point Laboratories Ltd. | CAPLIPOINT | 18,789.71 | 28.78 | 5.08 | 21.72 | 26.22 |
| Shilpa Medicare Ltd. | SHILPAMED | 16,862.09 | 56.58 | 6.26 | 9.82 | 11.43 |
| Glenmark Life Sciences Ltd. | ALIVUS | 16,722.7 | 27.73 | 4.8 | 18.41 | 24.61 |
Astrazeneca Pharma India Ltd. (ASTRAZEN) has a P/E ratio of 105.46x compared with the displayed peer median of 28.78x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 23.02% compares with a peer median of 14.2% across the companies shown in the table. ROCE stood at 31.24% versus the displayed peer median of 18.44%, providing a capital-efficiency comparison. Astrazeneca Pharma India Ltd. (ASTRAZEN) has a market capitalisation of Rs 17,888.63 crore. Among the 5 peers shown, 2 have a larger market capitalisation.
Why Investors Are Watching Astrazeneca Pharma India
- Astrazeneca Pharma India Share Price touched Rs 7,085.05, a fresh 52-week low.
- The stock closed at Rs 7,114.50 after a 0.57% decline from Rs 7,155.45.
- Market capitalisation is Rs 17,888.63 crore for Astrazeneca Pharma India Share Price.
- PE is 105.46 and PB is 19.78, both above the healthcare benchmark medians.
- ROE is 23.02% and ROCE is 31.24%, both above the sector benchmark medians.
About Astrazeneca Pharma India
Astrazeneca Pharma India Ltd. operates in the Healthcare sector and the Pharmaceuticals & Drugs industry. The supplied company data focuses on market position, financial ratios and quarterly financials rather than a broad product narrative. For Astrazeneca Pharma India Share Price readers on Univest, the company profile is best understood through its sector classification, valuation metrics, profitability ratios and recent financial results.
The latest supplied numbers show revenue of Rs 6,827.9 crore in Jun-26 and net profit of Rs 379.3 crore in the same period. That financial context is useful when reviewing Astrazeneca Pharma India Stock News alongside Astrazeneca Pharma India Fundamental Analysis. Univest keeps the company overview factual and anchored to the provided data.
Track Astrazeneca Pharma India Share Price on Univest
Use Astrazeneca Pharma India Ltd. (ASTRAZEN) live share-price page, Univest 52-week-low screener, Univest market blogs to review live stock data, yearly-low lists and related market analysis.
Readers can track Astrazeneca Pharma India Share Price on Univest for live price updates, valuation ratios, shareholding pattern, 52-week levels, company financials and market context. Univest also helps users follow Astrazeneca Pharma India Share Price Today, Astrazeneca Pharma India Stock News and Astrazeneca Pharma India Share Price Live in one place.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions
Why did Astrazeneca Pharma India Share Price hit a fresh 52-week low?
Ans. The supplied data confirms that Astrazeneca Pharma India Share Price touched Rs 7,085.05, a fresh 52-week low. It does not establish a company-specific catalyst, so the event should be read as a verified price move.
What is the current Astrazeneca Pharma India Share Price today?
Ans. Astrazeneca Pharma India Share Price is Rs 7,114.50, which is Rs 40.95 below the previous close of Rs 7,155.45. The stock also registered a fresh yearly low during the session.
What was the day’s low for Astrazeneca Pharma India Share Price?
Ans. The day’s low was Rs 7,085.05, and that is also the stock’s fresh 52-week low. The day’s high and opening price were both Rs 7,155.45, matching the previous close. The stock moved -0.57% during the session.
What is the market capitalisation of Astrazeneca Pharma India?
Ans. Astrazeneca Pharma India has a market capitalisation of Rs 17,888.63 crore. That places Astrazeneca Pharma India Share Price near the top of the supplied healthcare peer set by market value.
How does Astrazeneca Pharma India look on valuation?
Ans. Astrazeneca Pharma India Share Price trades on a PE of 105.46 and PB of 19.78. Both are well above the healthcare benchmark medians of 30.54 and 2.76, respectively. The company trades at a P/E ratio of 105.46x.
How do Astrazeneca Pharma India profitability ratios compare with the sector?
Ans. Astrazeneca Pharma India reports ROE of 23.02% and ROCE of 31.24%. Both are above the healthcare benchmark medians of 11.83% and 13.75%, which gives the stock useful fundamentals context. ROE stands at 23.02%.
How does Astrazeneca Pharma India compare with listed peers?
Ans. Astrazeneca Pharma India Share Price has a market cap close to Eris Lifesciences and Caplin Point Laboratories. Its ROE and ROCE are higher than the supplied peer set, while its PE is higher than most peers.
Where can readers track Astrazeneca Pharma India Share Price news?
Ans. Readers can track Astrazeneca Pharma India Share Price on Univest for price updates, company financials, shareholding pattern, valuation ratios and 52-week levels. The platform keeps Astrazeneca Pharma India Stock News in one place.
